APA-viite (7. p.)

Jadersten, M., Pellagatti, A., Forsblom, A., Emanuelsson, E., Merup, M., Samuelsson, J., . . . Hellstorm-Lindberg, E. (2005). Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.

Chicago-viite (17. p.)

Jadersten, M., A. Pellagatti, A. Forsblom, E. Emanuelsson, M. Merup, J. Samuelsson, J. Wainscoat, J. Boultwood, ja E. Hellstorm-Lindberg. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.

MLA-viite (9. p.)

Jadersten, M., et al. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.